Navigation Links
American Optometric Association Awards Acuvue(R) Oasys(TM) for Astigmatism With Seal of Acceptance for UV Absorbing Contact Lenses

Contact lens meets highest standard for contact lens UV protection

SEATTLE, June 26 /PRNewswire-FirstCall/ -- ACUVUE(R) OASYS(TM) Brand Contact Lenses for ASTIGMATISM, today became the fourth contact lens in the ACUVUE(R) family of products to receive the AOA Seal of Acceptance for Ultraviolet Absorbing Contact Lenses from the American Optometric Association's Commission on Ophthalmic Standards. The announcement was made in Seattle at Optometry's Meeting(TM), the annual meeting of the American Optometric Association (AOA).

In awarding the Seal of Acceptance, AOA's Commission on Ophthalmic Standards, which provides independent evaluation of ophthalmic related products, determined that ACUVUE(R) OASYS(TM) for ASTIGMATISM, just launched in the U.S. this week, meets AOA specifications for ultraviolet absorbing contact lenses. These specifications are in accordance with published standards of the American National Standards Institute (ANSI) and International Standards Organization (ISO).

"The greatest measure of UV protection can be achieved with a combination of UV-absorbing sunglasses, a wide brimmed hat, and UV-blocking contact lenses," says Jeffrey L. Weaver, OD, Director, Clinical Care Group, AOA.

All ACUVUE(R) Brand Contact Lenses offer effective UV-blocking, and among contact lens brands, only ACUVUE(R) ADVANCE(R) with HYDRACLEAR(R), ACUVUE(R) ADVANCE(R) for ASTIGMATISM, ACUVUE(R) OASYS(TM) with HYDRACLEAR(R) PLUS and ACUVUE(R) OASYS(TM) for ASTIGMATISM carry the AOA's Seal of Acceptance for Ultraviolet Absorbing Contact Lenses.

"Not all contact lens lines offer UV protection, and, of those that do, not all provide similar absorption levels," explains Sheila Hickson-Curran, Director, Medical Affairs, VISTAKON(R), Division of Johnson & Johnson Vision Care, Inc. "ACUVUE(R) ADVANCE(R), ACUVUE(R) ADVANCE(R) for ASTIGMATISM, ACUVUE(R) OASYS(TM) and ACUVUE(R) OASYS(TM) for ASTIGMATISM offer the highest level of UV-blocking available, blocking more than 90 percent of UVA rays and 99 percent of UVB rays that reach the lens.* ** On average, contact lenses without UV blocking block approximately 10% of UV-A radiation and 30% of UV-B radiation.

Because they cover the entire cornea and limbus, UV-blocking contact lenses offer an added level of protection when worn with UV blocking sunglasses. While many sunglasses will block UV rays that enter through the lenses, most do not prevent unfiltered rays from reaching the eyes through the sides, as well as the top, and/or bottom of the glasses. Due to their inability to block these peripheral rays, some sunglasses block as little as 50 percent of all UV radiation from reaching the eyes.

"Although UV-blocking contact lenses provide important added protection for patients, they should not be viewed as a stand-alone solution," notes Dr. Weaver. "Contact lenses should always be worn in conjunction with high-quality UV-blocking sunglasses and a wide-brimmed hat for maximum UV protection for the eyes."

ACUVUE(R) ADVANCE(R), ACUVUE(R) ADVANCE(R) for ASTIGMATISM, and ACUVUE(R) OASYS(TM) also carry the Seal of Acceptance for Ultraviolet Absorbing Contact Lenses from the World Council of Optometry.

ACUVUE(R) Brand Contact Lenses are available by prescription only for vision correction. An eye care professional will determine whether contact lenses are right for you. Although rare, serious eye problems can develop while wearing contact lenses. To help avoid these problems, follow the wear and replacement schedule and the lens care instructions provided by your eye doctor. Do not wear contact lenses if you have an eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. If one of these conditions occurs, contact your eye doctor immediately. For more information on proper wear, care and safety, talk to your eye care professional and ask for a Patient Instruction Guide, call 1-800-843-2020 or visit

ACUVUE(R), ACUVUE(R) ADVANCE(R), HYDRACLEAR(R), ACUVUE(R) OASYS(TM) , and VISTAKON(R) are trademarks of Johnson & Johnson Vision Care, Inc.

* Helps protect against transmission of harmful UV radiation to the cornea and into the eye.

** WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-Blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-Blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.

SOURCE Vistakon, Division of Johnson & Johnson Vision Care, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. American Airlines Miles for the Cure Campaign Raises More Than $600,000 for Susan G. Komen for the Cure(R)
2. American Right to Life Endorses U.S. Senator Roger Wickers Life at Conception Act
3. Alan J. Zuccari Featured by the American Health Care Association as a June PAC Member
4. Blue Cross and Blue Shield of Illinois Donates $25,000 to American Red Cross for Flood Disaster Recovery
5. 24 Million Americans Had Diabetes in 2007
6. American Lung Association Commends U.S. House of Representatives for Passage of Pulmonary and Cardiac Rehabilitation Act
7. American Red Cross and NSF Scrub Club(R) Announce Collaborative Agreement
8. Neglected infections of poverty in US disable hundreds of thousands of Americans annually
9. American HealthChoice CEO Dr. J.W. Stucki Provides Company Update
10. HealthGrades releases Fifth Annual Womens Health in American Hospitals study
11. American Association for Homecare Recommends Needed Improvements to Medicare Competitive Bidding Program, Set to Begin July 1
Post Your Comments:
(Date:11/29/2015)... ... , ... Khanna Vision Institute based in Los Angeles, announced that Dr. Khanna ... Peer Certification by the Board is done so the public knows that the Doctor ... after the completion of three years of training or Residency in Ophthalmology. This is ...
(Date:11/29/2015)... Aliso Viejo, CA (PRWEB) , ... November 29, ... ... is an all new and unique analog distortion effect tool designed specially for ... to their footage, and create limiltess looks with the easy-to-use modification controls. Destoying ...
(Date:11/28/2015)... ... November 28, 2015 , ... ... services, has added Chris Hafey and Claude Hooton to its board of directors. ... of North America (RSNA) 2015 Annual Meeting and continues to strategically transform its ...
(Date:11/28/2015)... ... ... 30th at 6:00 a.m. EST until 11:59 p.m. EST, customers will be ... 20% off orders $80 or more to free gifts with purchases, there will be a ... competitive e-commerce website for skin care and cosmetic needs, customers will save on already discounted ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... According to ... the recent 2015 American Dental Association meeting in Washington D.C. revolved around the fact ... a patient’s overall health. The talk stressed the link between periodontal disease (more commonly ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Nov. 26, 2015 ... of the "2016 Global Tumor Marker ... Volume and Sales Segment Forecasts, Innovative Technologies, ... report to their offering. --> ... the "2016 Global Tumor Marker Testing ...
(Date:11/26/2015)... November 26, 2015 --> ... combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... approach blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... has found that immunotherapy can be efficiently combined with ...
(Date:11/26/2015)... 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ... is expected to boost the market growth, as 3D bioprinting ... --> 3D bioprinting market is expected to reach ... by Grand View Research Inc. Rising prevalence of chronic diseases ...
Breaking Medicine Technology: